Ende Eric J 4
4 · Matinas BioPharma Holdings, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Ende Eric J
Director
Transactions
- Award
Stock option (right to buy)
2022-11-14+142,657→ 142,657 totalExercise: $0.73Exp: 2032-11-14→ Common Stock (142,657 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.